Life-Sciences Industry Gets Boost With $150 Million Fund

Montreal’s Teralys Capital is investing $65 million in a new $150-million life-sciences fund along with U.S. multinational partner Eli Lilly’s $40 million and a commitment that will help Quebec’s biotech industry recover its growth momentum.
The Gazette